Cancer is a deadly disease that is slowly becoming a nightmare in the lives of many families in the international community. The disease has now become a threat to the longevity and existence of man. People from all walks of life, regardless of their age and race can get the medical condition as long as they are alive. The condition is very dangerous, and when it is discovered in the late stages, it can lead to death. Although there are a lot of medical professionals who have spent years in cancer research, not much has been done to treat the people living with the disease. The advancements in the medical field have not made things better for the cancer patients. The form of treatments for the individuals living with the disease is very costly, and it has severe effects on the patients who are in the last stages of cancer.
Many companies from all over the world have emerged so that they can come up with a reliable and effective form of cancer therapy. One of these companies is known as Seattle Genetics. The company is believed to be making great strides in the oncology department, and this has been made possible by Clay Siegall, the founder and also the president of the biotechnology firm. The businessman has always been passionate about science and medical research. This passion motivated him to venture into the oncology world and make a difference in the lives of the people who are struggling to cure cancer.
Clay Siegall is a prominent name when it comes to the cancer and research field. The businessman studied zoology at some of the best learning institutions in the entire world. After finishing his education, the scientist discovered that cancer was slowly making the lives of many people a nightmare. One of his close relatives passed away due to the disease. When growing up, the young Siegall watched as his relative struggled with the cancer treatment that was only making things worse for him. This realization motivated him to study genetics in one of the most prominent universities in the world. When he completed his Ph.D, the businessman was fortunate to work in several institutions so that he could acquire enough expertise in the biotechnology world.
After spending several years in cancer and research, Siegall felt the need to establish a biotechnology firm that would come up with the best form of treatment for cancer. Seattle Genetics has been doing very well, and it has developed several drugs that are used all over the world.